Loading stock data…
Loading stock data…
US$89.57
Get one email when CORT crosses your level. Checked every 15 minutes during market hours.
▼ -0.90 (-0.99%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
61.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
4.90
Bearish momentumMACD below its signal line (5.80).
50-day average
73.43
Price aboveShort-term trend reference.
200-day average
61.05
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Corcept Therapeutics Incorporated is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing medications that address severe endocrine, metabolic, oncologic, and neurologic disorders. The company’s core scientific approach is based on modulating the effects of the hormone cortisol, which plays a central role in multiple disease pathways. Corcept Therapeutics today develops therapies for conditions such as hypercortisolism and is evaluating compounds in c…
www.corcept.com2 strong buy · 8 buy · 2 hold · 0 sell · 0 strong sell (12 analysts, 2026-07-01)
2 strong buy · 8 buy · 2 hold · 0 sell · 0 strong sell (12 analysts, 2026-06-01)
2 strong buy · 7 buy · 3 hold · 0 sell · 0 strong sell (12 analysts, 2026-05-01)
2 strong buy · 7 buy · 3 hold · 0 sell · 0 strong sell (12 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-04-30 | -0.14 | -0.3 | ✗ Miss |
| 2026-03-19 | 0.16 | 0.17 | ✓ Beat |
| 2026-02-24 | 0.33 | 0.2 | ✗ Miss |
| 2025-12-05 | -0.02 | -0.1 | ✗ Miss |
| 2025-11-04 | 0.14 | 0.16 | ✓ Beat |
| 2025-10-08 | 0.04 | 0.04 | ✓ Beat |
| 2025-07-31 | 0.19 | 0.29 | ✓ Beat |
Companies in the same industry, via Finnhub